Keywords: AMPKα2; AMP-activated protein kinase α2; CT; computerized tomography; CI; confidence interval; EPIC-Norfolk; European Investigation into Cancer; HbA1c; higher hemoglobin A1c; HOMA-β; homeostatic model assessment method; MKP1; MAP kinase phosphatase-1;